NYSE / NASDAQ · SEC EDGAR
Equity research
Start with company fundamentals. Compare growth and capital returns, then narrow the research to the companies that meet your criteria.
Research preview · Quarterly financial statements · No price quotes · Not financial advice
Example screens
- Best combined rank222Issuers with both EPS acceleration and ROE, highest rank first.
- Profitable growth43ROE at least 15% and revenue growth at least 10%.
- Earnings acceleration376EPS acceleration at or above zero, largest first.
- High return on equity120ROE at least 25%, highest first.
- NYSE only128The same ranking with NYSE listings only.
Example lists from a senior trader
- All 47 screens9191 of 279 companies are in this screen.
- 2026 · 06-27 14023566 of 8 companies are in this screen.
- 2026 · 06-27 14000344 of 10 companies are in this screen.
- 2026 · 06-27 14012944 of 9 companies are in this screen.
- 2026 · 06-27 14014744 of 9 companies are in this screen.
- 2026 · 06-27 14015833 of 9 companies are in this screen.
- 2026 · 06-27 14022744 of 9 companies are in this screen.
- 2026 · 06-27 14031844 of 10 companies are in this screen.
- 2026 · 06-27 14081955 of 8 companies are in this screen.
| Company | Combined rank | EPS acceleration | Revenue growth | ROE | Net margin | Reporting period |
|---|---|---|---|---|---|---|
| EAIENTERGY ARKANSAS, LLCNYSE | — | — | 5.9% | — | — | 2026-06-30Filed 2026-07-31 |
| EBCEastern Bankshares, Inc.NASDAQ | — | — | 18.8% | 8.8% | 257.2% | 2026-06-30Filed 2026-08-07 |
| EBFENNIS, INC.NYSE | — | — | 1.5% | 13.7% | 10.8% | 2026-05-31Filed 2026-07-01 |
| EBSEmergent BioSolutions Inc.NYSE | — | — | 66.3% | -51.8% | -23.0% | 2026-06-30Filed 2026-08-06 |
| ECHOEchoStar CORPNASDAQ | — | — | -4.0% | — | — | 2026-06-30Filed 2026-08-03 |
| ECORelectroCore, Inc.NASDAQ | — | — | 28.0% | — | -40.0% | 2026-06-30Filed 2026-08-06 |
| ECVTEcovyst Inc.NYSE | — | — | 42.0% | -10.4% | -7.1% | 2026-06-30Filed 2026-08-06 |
| EDCONSOLIDATED EDISON INCNYSE | — | — | 7.0% | 8.4% | 12.4% | 2026-03-31Filed 2026-05-07 |
| EDBLEdible Garden AG IncNASDAQ | — | — | 12.8% | -126.7% | -51.0% | 2026-06-30Filed 2026-08-14 |
| EDITEditas Medicine, Inc.NASDAQ | — | — | 232.3% | -70.2% | -157.3% | 2026-06-30Filed 2026-08-05 |
| EDSAEdesa Biotech, Inc.NASDAQ | — | — | — | -160.0% | — | 2026-06-30Filed 2026-08-13 |
| EDUCEDUCATIONAL DEVELOPMENT CORPNASDAQ | — | — | -33.1% | 4.8% | 9.7% | 2026-05-31Filed 2026-07-09 |
| EDVAEndovia Health Sciences, Inc.NYSE | — | — | -93.8% | — | — | 2026-06-30Filed 2026-08-19 |
| EEExcelerate Energy, Inc.NYSE | — | 166.2 pp | 61.0% | — | — | 2026-06-30Filed 2026-08-06 |
| EFOIENERGY FOCUS, INC/DENASDAQ | — | — | 228.0% | -45.4% | -23.4% | 2026-06-30Filed 2026-08-11 |
| EFSIEAGLE FINANCIAL SERVICES INCNASDAQ | — | — | — | 9.6% | — | 2026-06-30Filed 2026-08-10 |
| EGANEGAIN CorpNASDAQ | — | — | -4.7% | 10.5% | 9.7% | 2026-06-30Filed 2026-09-10 |
| EGBNEAGLE BANCORP INCNASDAQ | — | — | — | -4.2% | — | 2026-06-30Filed 2026-08-06 |
| EGHAEGH Acquisition Corp.NASDAQ | — | — | — | — | — | 2026-06-30Filed 2026-08-12 |
| EGHT8X8 INC /DE/NASDAQ | — | — | 4.9% | 3.2% | 0.6% | 2026-06-30Filed 2026-08-05 |
| EGPEASTGROUP PROPERTIES INCNYSE | — | -38.6 pp | 9.1% | — | — | 2026-06-30Filed 2026-07-22 |
| EHTHeHealth, Inc.NASDAQ | — | — | -44.8% | 5.0% | 5.4% | 2026-06-30Filed 2026-08-05 |
| EIKNEikon Therapeutics, Inc.NASDAQ | — | — | — | — | — | 2026-06-30Filed 2026-08-13 |
| EIXEDISON INTERNATIONALNYSE | — | — | 7.7% | 20.5% | 18.1% | 2026-03-31Filed 2026-04-28 |
| ELESTEE LAUDER COMPANIES INCNYSE | — | — | 6.3% | — | — | 2026-06-30Filed 2026-08-19 |
| ELABPMGC Holdings Inc.NASDAQ | — | — | — | -80.6% | -523.0% | 2026-06-30Filed 2026-08-14 |
| ELDNEledon Pharmaceuticals, Inc.NASDAQ | — | — | — | -298.6% | — | 2026-06-30Filed 2026-08-13 |
| ELMTElmet Group Co.NASDAQ | — | -233.3 pp | 35.2% | — | — | 2026-07-03Filed 2026-08-13 |
| ELOXEloxx Pharmaceuticals, Inc.NASDAQ | — | — | — | — | — | 2026-06-30Filed 2026-08-11 |
| ELSEQUITY LIFESTYLE PROPERTIES INCNYSE | — | — | 2.7% | — | — | 2026-03-31Filed 2026-04-28 |
| ELTXElicio Therapeutics, Inc.NASDAQ | — | — | — | -476.8% | — | 2026-06-30Filed 2026-08-13 |
| ELUTELUTIA INC.NASDAQ | — | — | — | 329.0% | — | 2026-06-30Filed 2026-08-14 |
| ELVNEnliven Therapeutics, Inc.NASDAQ | — | — | — | -11.8% | — | 2026-06-30Filed 2026-08-05 |
| ELWTElauwit Connection, Inc.NASDAQ | — | — | -46.4% | — | -45.3% | 2026-06-30Filed 2026-08-19 |
| EMATEvolution Metals & Technologies Corp.NASDAQ | — | — | — | — | — | 2026-06-30Filed 2026-08-17 |
| EMBCEmbecta Corp.NASDAQ | — | 63.7 pp | -8.1% | — | 8.6% | 2026-06-30Filed 2026-08-07 |
| EMISEmmis Acquisition Corp.NASDAQ | — | — | — | — | — | 2026-06-30Filed 2026-08-06 |
| EMPDEmpery Digital Inc.NASDAQ | — | — | -57.9% | -240.0% | — | 2026-06-30Filed 2026-08-07 |
| EMREMERSON ELECTRIC CONYSE | — | — | 7.0% | 12.7% | 13.8% | 2026-06-30Filed 2026-08-04 |
| ENGNenGene Therapeutics Inc.NASDAQ | — | — | — | -56.6% | — | 2026-07-31Filed 2026-09-08 |
| ENHAEnhanced Group Inc.NYSE | — | — | — | -2474.6% | — | 2026-06-30Filed 2026-08-14 |
| ENOVEnovis CORPNYSE | — | — | 3.2% | -74.6% | -48.0% | 2026-07-03Filed 2026-08-06 |
| ENPHEnphase Energy, Inc.NASDAQ | — | — | -20.6% | 12.2% | 9.6% | 2026-03-31Filed 2026-04-28 |
| ENSEnerSysNYSE | — | — | — | 17.9% | — | 2026-07-05Filed 2026-08-12 |
| ENSCEnsysce Biosciences, Inc.NASDAQ | — | — | -15.1% | — | — | 2026-06-30Filed 2026-08-13 |
| ENTAENANTA PHARMACEUTICALS INCNASDAQ | — | — | -21.6% | -62.6% | -96.9% | 2026-06-30Filed 2026-08-12 |
| ENVBEnveric Biosciences, Inc.NASDAQ | — | — | — | -108.0% | — | 2026-06-30Filed 2026-08-14 |
| ENVXEnovix CorpNASDAQ | — | — | 20.8% | -81.0% | -473.9% | 2026-07-05Filed 2026-08-12 |
| EOLSEvolus, Inc.NASDAQ | — | — | 21.2% | — | -10.8% | 2026-06-30Filed 2026-08-05 |
| EOSEEos Energy Enterprises, Inc.NASDAQ | — | — | 351.4% | — | -246.8% | 2026-06-30Filed 2026-08-05 |
How the lists overlap
EPS acceleration is the change in year-over-year quarterly EPS growth, expressed in percentage points. Revenue growth compares matching quarters a year apart. ROE divides four consecutive quarters of net income by equity at the same latest reporting date.
The combined rank averages the EPS acceleration and ROE percentiles among issuers with both metrics. It ranges from 0 to 100 and describes relative position within this covered group. It is not a probability or a performance estimate.
Net margin uses four consecutive quarters with matching revenue and net income. Missing quarters stay unavailable; additive fourth-quarter values may be derived from annual minus nine-month totals known at the filing date. EPS is never derived this way.
What this data covers
Source: SEC EDGAR company facts. Each value must have been filed on or before the displayed as-of date. Reporting periods older than 185 days are excluded.
The current exchange universe includes multiple security types. The screen shows one ticker per issuer with supported US-GAAP facts; it is not a complete historical stock universe. Missing companies and ratios are coverage gaps, not negative assessments.
Snapshots update daily. Close-price series are shown for the companies the BibaMoney price store covers — the coverage line above states how many of the current matches that is, and a card without a series says so instead of drawing a line. Sector metadata and validated price outcomes are not included: no price outcome in this screen has been checked out of sample.
Macro context: the 10Y–3M Treasury curve was non-inverted on 2026-09-18. Source: FRED / Federal Reserve.